KOPRAN
Back to Balance Sheet
|
KOPRAN Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹346 Cr | ₹289 Cr | ₹219 Cr | ₹177 Cr | ₹152 Cr |
What is the latest Total Current Liabilities ratio of KOPRAN ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹346 Cr |
| Mar2025 | ₹289 Cr |
| Mar2024 | ₹219 Cr |
| Mar2023 | ₹177 Cr |
| Mar2022 | ₹152 Cr |
How is Total Current Liabilities of KOPRAN Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹346 Cr | 19.80 | |
| Mar2025 | ₹289 Cr | 32.23 | |
| Mar2024 | ₹219 Cr | 23.48 | |
| Mar2023 | ₹177 Cr | 16.75 | |
| Mar2022 | ₹152 Cr | - | |
Compare Total Current Liabilities of peers of KOPRAN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KOPRAN | ₹967.0 Cr | 5.3% | -0.8% | 29.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | -1.2% | -2.2% | 15.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹227,958.0 Cr | 1% | 16.3% | 39.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,990.0 Cr | 3.2% | -0.8% | 38.6% | Stock Analytics | |
| CIPLA | ₹116,141.0 Cr | -0.9% | 1.6% | -9.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,604.4 Cr | -1.7% | -0.1% | -6.5% | Stock Analytics | |
KOPRAN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | 5.3% |
-0.8% |
29.2% |
| SENSEX | -0.7% |
0.1% |
-3.4% |
You may also like the below Video Courses